merck millipore,默克密理博,CYL4039,PrecisION™ hERG ion channel membrane preparation

搜索"Merck Millipore 密理愽"产品

Merck Millipore 默克密理愽

当前位置：首页 > >Merck Millipore > 生命科学研究
生命科学研究

merck millipore,默克密理博,CYL4039,PrecisION™ hERG ion channel membrane preparation
产品名称：PrecisION™ hERG ion channel membrane preparation
产品型号：CYL4039
Human ERG ion channel membrane preparation for Radioligand binding Assays.

merck millipore,默克密理博,CYL4039,PrecisION™ hERG ion channel membrane preparation

产品介绍

merck millipore,默克密理博,CYL4039,PrecisION™ hERG ion channel membrane preparation

重要规格表

应用说明	品种	宿主细胞	蛋白靶
Radioligand binding assay	Human	293 cell line	hERG

描述
产品目录编号	CYL4039
商名	PrecisION
描述	PrecisION™ hERG ion channel membrane preparation
概述	Human ERG
背景信息	The human ether-a-go-go related gene (hERG) is a potassium ion channel which is essential for normal cardiac repolarization. In drug screening models, the hERG K⁺ channel has been indicated to inhibit a wide variety of compounds, and its blockage can lead to cardiac QT interval prolongation and life threatening arrhythmias (Murphy et al. 2006). Cardiac safety relating to I_Kr K⁺ channels has become a major concern of regulatory agencies, as hERG channel inhibition has been identified as the firmest link to QT prolongation (Chiu et al. 2004). Millipore's hERG membrane preparations are crude membrane preparations made from HEK293 stable recombinant cell lines (Millipore cat. # CYL3039), which are ideal HTS tools for screening antagonists against the hERG channel. The membrane preparations exhibit a Kd of 5.2 nM for [³H]-Astemizole. With 10 μg/well hERG Membrane Prep and 3.0 nM [³H]-Astemizole, a greater than 4-fold signal-to-background ratio was obtained.

产品信息
格式	Membranes
演示	Liquid in packaging buffer: 50 mM Tris pH 7.4, 10% glycerol and 1% BSA with no preservatives. Packaging method: Membrane protein was adjusted to the indicated concentration in packaging buffer, rapidly frozen, and stored at -80°C.

应用
应用	Human ERG ion channel membrane preparation for Radioligand binding Assays.
应用说明	Radioligand binding assay

生物信息
品种	Human
Entrez基因编号	U04270
宿主细胞	293 cell line
蛋白靶	hERG
靶子系列	Potassium
孵化条件	RECOMMENDED ASSAY CONDITIONS: Membranes are mixed with radioactive ligand and unlabeled competitor (see Figures 1 and 2 for concentrations tested) in binding buffer in a nonbinding 96-well plate, and incubated for 1-2 h. Prior to filtration, an FB 96-well harvest plate (Millipore cat. # MAHF B1H) is coated with 0.33% polyethyleneimine for 30 min, then washed with 25 mM Tris, pH 7.4, 130 mM NaCl, 5 mM KCl, 0.8 mM CaCl₂, 0.1% BSA. Binding reaction is transferred to the filter plate, and washed 6 times (250μL per well per wash) with Wash Buffer. The plate is dried and counted. Binding buffer: 10 mM Hepes, pH 7.4, 130 mM NaCl, 5 mM KCl, 0.8 mM MgCl₂, 1 mM NaEGTA, 10 mM glucose, 0.1% BSA, filtered and stored at 4°C Radioligand: [³H]-Astemizole (Perkin Elmer # NET-1140) Wash Buffer: 25 mM Tris, pH 7.4, 130 mM NaCl, 5 mM KCl, 0.8 mM MgCl₂, 0.05 mM CaCl₂, 0.1% BSA, filtered and stored at 4°C One package contains enough membranes for at least 200 assays (units), where a unit is the amount of membrane that will yield greater than 4-fold signal: background with ³H-labeled Astemizole.

产品使用声明

质量保证

Table 1. Signal: background and specific binding values obtained in a competition binding assay for the hERG membrane prep.

	10 µg/well
Signal:Background	4.6
Specific Binding (cpm)	435

SPECIFICATIONS: 1 unit = 10 μg membrane preparation with [³H]-astemizole
Bmax with [³H]-astemizole: 6.7 pmol/mg
Kd for [³H]-astemizole: 5.2 nM

Table 2. Rank order comparison of various small molecule hERG inhibitors using [³H]-astemizole binding assay and E-Phys assays:

	Binding Ki (nM) with hERG membrane preps		Electrophysiology IC50 (nM) with hERG cell lines
	Millipore CYL4039M	Literature value*	Millipore CYL4039 by IonWorks PPC	Millipore CYL4039 by PatchExpress	Literature value by Patch Clamp
Astemizole	3.4 ± 0.7	3.3 ± 0.7	4.6 ± 0.003	ND	0.5
Dofetilide	5.8 ± 2.4	28 ± 6	ND	ND	15.3 ± 2.5
E-4031	6.1 ± 0.8	58 ± 5	115 ± 0.02	144 ± 44	14
Pimozide	18.8 ± 2.3	14 ± 4	ND	ND	18
Cisapride	104.9 ± 30.9	123 ± 25	75.6 ± 0.02	5 ± 1	44.5 ± 10.6
Haloperidol	241.4 ± 21.4	234 ± 20	ND	ND	63
Risperidone	> 4000	4302 ± 319	ND	ND	167
Verapimil	> 4000	3902 ± 529	1332 ± 120	3100 ± 400	830

*Data obtained from Chiu et al., 2004

使用声明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.